Overview

Update
Total Equity Funding
$48.39M in 8 Rounds from 2 Investors
Most Recent Funding
$2.84M Venture on September 3, 2013
Headquarters:
Baltimore, MD
Description:
Gliknik develops therapies for patients with cancer and immune disorders.
Founders:
,
Categories:
Health Care, Biotechnology, Medical
Website:
http://www.gliknik.com

Company Details

Update
Founded:
2007
Aliases:
Gliknik Inc
Contact:
4106854259
Employees:
1 - 10 | 3 in Crunchbase

Gliknik, Inc., a biopharmaceuticals company, develops therapies for patients with cancer and immune disorders. Its Immunomodulator Platform involves in off-the-shelf peptide drugs that increase CD4, CD8, and antibody immune responses against cancer; Stradomer Platform produces drugs designed to mimic the eficacy of pooled human intravenous immunoglobulin; and Stradobody Platform produces compounds that are similar to moncolonal antibodies for tumor cell killing. The company was founded in 2007 and is based in Baltimore, Maryland.

Funding Rounds (8) - $48.39M

Update
DateAmount / RoundValuationLead InvestorInvestors
Sep, 2013$2.84M / Venture0
May, 2013$20M / Venture0
Apr, 2013$9.83M / Venture0
Oct, 2012$4.9M / Series B1
Sep, 2011$2.04M / Venture0
Jan, 2011$3.5M / Venture1
Sep, 2010$2.4M / Venture0
Jan, 2010$2.89M / Series A0

Investors (2)

InvestorRound(s)Partner(s)
Series B (Lead)-
Venture-

Current Team (3)

Update

Board Members and Advisors (4)

Update

Offices/Locations (1)

Update
  • Office

    801 W. Baltimore Street

    Suite 501A

    Baltimore, MD 21201

    USA

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos